Biogen is also hiring!

Discussion in 'Sage Therapeutics' started by anonymous, Aug 3, 2020 at 12:48 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Many positions for their ALZ drug that should be approved soon. I just accepted an offer with a 165K base and a fair amount of RSUs. Package valued well above 200K with bonus.

    Good luck to all!
     

  2. anonymous

    anonymous Guest

    Where is your territory? Biogen has a hold on new employees - - - I call BS on your post!! Quit trying to cause trouble.
     
  3. anonymous

    anonymous Guest

    A number of people have been hired and start today. A number of managers have been in place for quite some time. NDA field but not yet accepted by FDA. Good
    Luck to all
     
  4. anonymous

    anonymous Guest

    So sorry you didn't make it through the interviewing process. Good luck on future job interviews!
     
  5. anonymous

    anonymous Guest


    You couldn't be more wrong. They are actively hiring right now. Where do you get your information?
     
  6. anonymous

    anonymous Guest

    I believe you are mistaken. I also recently interviewed with Biogen. Even though I was not their final choice I did accept a position in the growing digital therapeutics arena. Compensation includes a base salary of $157,000 and a hefty amount of stock options plus $1,100/ month as a car allowance.

    Glad to see many are landing on their feet with new gigs!
     
  7. anonymous

    anonymous Guest

    Irresponsibly hiring IMO Drug is not a slam dunk for approval and if
    More studies are required or the drug is flat out not approved everyone will be gone. Might be another short term gig. Good luck to all
     
  8. anonymous

    anonymous Guest

    Biogen ALZ earliest approval is March 2021. BS, they are hiring a sales force now! In addition, Wall Street speculation on FDA approval: FDA approval is far from assured. The drug failed a Phase 3 trial last year, only for Biogen (ticker: BIIB) to decide to move forward with it anyway, based on what the company says are subsequent analyses showing the data were better than they had seemed. Reanalyze the data? Sounds "fishy" to me.
     
  9. anonymous

    anonymous Guest

    I hope the drug is approved for the sake of those who went to work there and more importantly for the ALZ patients who need it.
     
  10. anonymous

    anonymous Guest

    why would they hire anyone dumb enough to take a job at Sage?
     
  11. anonymous

    anonymous Guest

    Better question. Why would anyone be stupid enough to go to Biogen/?
     
  12. anonymous

    anonymous Guest

    You're right! It is a very very stupid move. Biogen sucks
     
  13. anonymous

    anonymous Guest

    What’s wrong with you???